Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial by Hui Zhou, Jun Zhu, Yu Yang, Wei Yang, Liling Zhang, Lihong Liu, Mingzhi Zhang, Chuan He, Mei Zhang, Sujun Gao, Zhiming Li, Min Zhou, Hongmei Jing, Qingyuan Zhang, Ying Cheng, Yuqin Song, Zhengzi Qian, Xiuhua Sun, Wenyu Li, Haiyan Yang, Feng Yan, Ying Xiang, Bing Xu, Weihua Zhang, Xiaohong Zhang, Jie Jin, Huilan Liu, Weili Zhao, Ru Feng, Wenqi Jiang, Hong Cen, Fangfang Lv, Yunhong Huang, Ding Yu, Qunyi Guo, Lie Lin, Jianzhen Shen, Donghua Zhang, Jishi Wang, Xiongpeng Zhu, Meizuo Zhong, Jingbo Wang, Zhao Wang, Hongguo Zhao

Get full text